Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies
External Expert Profile
Jane de Vries
Latest Publications
Navigating the Landscape of Digital Health – United Kingdom
Supporting the Era of Green Pharmaceuticals in the UK
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
Read more
© NCI/Unsplash
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers
Read more
© Mayer Tawfik/Unsplash
The Lower Drug Costs Now Act and Pharmaceutical Innovation
